CGT
NVO

Capital Guardian Trust’s Novo Nordisk NVO Stock Holding History

Capital Guardian Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$61M Buy
2,397,434
+88,700
+4% +$2.19M 0.82% 41
2019
Q1 		$60.1M Buy
2,308,734
+332,290
+17% +$8.17M 0.8% 45
2018
Q4 		$45.5M Buy
1,976,444
+75,036
+4% +$1.67M 0.72% 56
2018
Q3 		$44.8M Buy
1,901,408
+134,010
+8% +$3.27M 0.6% 73
2018
Q2 		$40.8M Buy
1,767,398
+109,518
+7% +$2.6M 0.58% 74
2018
Q1 		$40.8M Buy
1,657,880
+240,098
+17% +$6.3M 0.58% 69
2017
Q4 		$38M Buy
+1,417,782
New +$36.1M 0.54% 74
2017
Q2 		– Sell
-2,484,044
Closed -$42.6M – 439
2017
Q1 		$42.6M Sell
2,484,044
-26,088
-1% -$454K 0.32% 108
2016
Q4 		$45M Sell
2,510,132
-16,010
-0.6% -$290K 0.35% 98
2016
Q3 		$52.5M Buy
2,526,142
+286,982
+13% +$7.12M 0.4% 91
2016
Q2 		$60.2M Buy
2,239,160
+33,720
+2% +$925K 0.46% 82
2016
Q1 		$59.8M Buy
2,205,440
+21,642
+1% +$580K 0.46% 81
2015
Q4 		$63.4M Buy
2,183,798
+94,444
+5% +$2.61M 0.49% 76
2015
Q3 		$56.7M Buy
2,089,354
+72,098
+4% +$2.04M 0.46% 84
2015
Q2 		$55.2M Buy
2,017,256
+84,044
+4% +$2.36M 0.4% 90
2015
Q1 		$51.6M Sell
1,933,212
-33,648
-2% -$775K 0.38% 90
2014
Q4 		$41.6M Buy
1,966,860
+188,590
+11% +$4.21M 0.29% 98
2014
Q3 		$42.3M Buy
1,778,270
+134,784
+8% +$3.1M 0.3% 93
2014
Q2 		$38M Buy
1,643,486
+45,122
+3% +$996K 0.26% 101
2014
Q1 		$36.5M Buy
1,598,364
+121,654
+8% +$2.59M 0.25% 108
2013
Q4 		$27.3M Buy
1,476,710
+150,940
+11% +$2.63M 0.18% 115
2013
Q3 		$22.4M Buy
1,325,770
+133,270
+11% +$2.24M 0.16% 118
2013
Q2 		$18.5M Buy
+1,192,500
New +$19.8M 0.13% 130

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Capital Guardian Trust's NVO Position: Q2 2019 in Review

Capital Guardian Trust increased its Novo Nordisk (NVO) stake by 3.8% in Q2 2019, buying an estimated $2.19M and bringing the position to 2,397,434 shares worth $61M. The position accounts for 0.82% of the portfolio, ranked #41.

Capital Guardian Trust first reported a position in NVO in Q2 2013 and has held it in 23 quarters since. The position peaked at $63.4M in Q4 2015. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Capital Guardian Trust held 2,397,434 shares of Novo Nordisk worth $61M as of Q2 2019.
  • Capital Guardian Trust bought 88,700 Novo Nordisk shares in Q2 2019, an estimated $2.19M.
  • Novo Nordisk made up 0.82% of Capital Guardian Trust's portfolio in Q2 2019, its #41 holding.
  • Capital Guardian Trust first reported a position in Novo Nordisk in Q2 2013 and has held it in 23 quarters since.
  • Capital Guardian Trust's Novo Nordisk position peaked at $63.4M in Q4 2015.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.